Skip to content
value.today

Diasome Pharmaceuticals LLC

🇺🇸 Conshohocken, Pennsylvania, USAPharmaceuticalsFounded 2008
Total raised
$46 M
6 rounds on record
Latest round
$3 M
Jul 2024
First round on record
Mar 2008
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Diasome Pharmaceuticals LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2024$3 MNo. 6$2 to $10 million

Diasome Pharmaceuticals LLC: Raise no. 6, Jul 2024

Investors in this round

4 investors had bought by the notice of Aug 15, 2024: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $16 M offered; $12 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$152,074
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert Geho · Executive Officer, Director
  • W. Blair Geho · Executive Officer, Director
  • Cosme Blair Ordonez · Director
  • Frank Blair McCaney · Director
  • Peter Blair Tollman · Director
  • Thomas Blair McDonald · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Geho, Chief Executive Officer. Newest notice filed Aug 15, 2024. Read the notice at the SEC.

equity, optionsSEC
Jun 2023$9 MNo. 5$2 to $10 million

Diasome Pharmaceuticals LLC: Raise no. 5, Jun 2023

Investors in this round

2 investors had bought by the notice of Jun 30, 2023: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $15 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$349,999
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert Geho · Executive Officer, Director
  • Frank Blair McCaney · Director
  • Marc Blair Penn · Director
  • Peter Blair Tollman · Director
  • Thomas Blair McDonald · Director
  • W. Blair Geho · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Geho, Ceo. Newest notice filed Jun 30, 2023. Read the notice at the SEC.

equitySEC
Aug 2022$17 MNo. 4$10 to $50 million

Diasome Pharmaceuticals LLC: Raise no. 4, Aug 2022

Investors in this round

40 investors had bought by the notice of Sep 8, 2022: 40 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $19 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$537,746
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert Geho · Executive Officer, Director, Promoter
  • Frank Blair McCaney · Director
  • Marc Blair Penn · Director
  • Thomas Blair McDonald · Director
  • W. Blair Geho · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The Total Offering Amount and Total Amount Sold include convertible debt and the securities issuable hereto.”

Signed by Robert Geho, Chief Executive Officer. Newest notice filed Sep 8, 2022. Read the notice at the SEC.

equitySEC
Sep 2020$2 MNo. 3Under $2 million

Diasome Pharmaceuticals LLC: Raise no. 3, Sep 2020

Investors in this round

6 investors had bought by the notice of Dec 23, 2020: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert Geho · Executive Officer, Director, Promoter
  • Frank Blair McCaney · Director
  • Marc Blair Penn · Director
  • Thomas Blair McDonald · Director
  • W. Blair Geho · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Geho, Chief Executive Officer. Newest notice filed Dec 23, 2020. Read the notice at the SEC.

debt, optionsSEC
Mar 2020$3 MNo. 2$2 to $10 million

Diasome Pharmaceuticals LLC: Raise no. 2, Mar 2020

Investors in this round

20 investors had bought by the notice of Apr 1, 2020: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert Geho · Executive Officer, Director, Promoter
  • Frank Blair McCaney · Director
  • Marc Blair Penn · Director
  • Thomas Blair McDonald · Director
  • W. Blair Geho · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Geho, Chief Executive Officer. Newest notice filed Apr 1, 2020. Read the notice at the SEC.

equitySEC
Mar 2008$13 MNo. 1$10 to $50 million

Diasome Pharmaceuticals LLC: Raise no. 1, Mar 2008

Investors in this round

9 investors had bought by the notice of Apr 13, 2009: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $13 M offered; $1 M still to sell
Smallest investment taken
$13,752
What was sold
equity, debt
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Pa

People named in the notice

  • Len Rosenberg · Executive Officer, Director
  • Robert Geho · Executive Officer
  • W. Blair Geho · Executive Officer, Director
  • Brenda Gavin · Director
  • Devang Kantesaria · Director
  • Richard Caruso · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Len Rosenberg, President. Newest notice filed Apr 13, 2009. Read the notice at the SEC.

equity, debtSEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Diasome Pharmaceuticals LLC chose not to state its revenue in its newest notice of a funding round (Aug 2024).

    SEC Form D · Aug 2024

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Aug 2024

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Diasome Pharmaceuticals LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Diasome Pharmaceuticals LLC
NameRoleNamed in
Robert GehoExecutive officerAug 2024
W. Blair GehoExecutive officerAug 2024
Len RosenbergExecutive officerApr 2009
Cosme Blair OrdonezDirectorAug 2024
Frank Blair McCaneyDirectorAug 2024
Peter Blair TollmanDirectorAug 2024
Robert GehoDirectorAug 2024
Thomas Blair McDonaldDirectorAug 2024
W. Blair GehoDirectorAug 2024
Marc Blair PennDirectorJun 2023
Brenda GavinDirectorApr 2009
Devang KantesariaDirectorApr 2009
Len RosenbergDirectorApr 2009
Richard CarusoDirectorApr 2009
Robert GehoPromoterSep 2022